REPORT ID 2317

United States Vinorelbine Market Report 2017

Publish Date
8-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the United States Vinorelbine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Vinorelbine in these regions, from 2012 to 2022 (forecast).

United States Vinorelbine market competition by top manufacturers/players, with Vinorelbine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pierre Fabre Pharmaceuticals, Inc.
    TEVA Pharms
    Hospira, Inc.
    West-Ward Pharmaceuticals Corp.
    Fresenius Kabi
    EBEWE Pharma (Sandoz A Novartis Division)
    Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
    Mylan
    Dr. Reddy's Laboratories
    Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
    Nanjing Cuccess Pharmaceutical Co., Ltd
    Qilu Pharmaceutical (Hainan) Co., Ltd.
    Sinopharm A-Think Pharmaceutical Co., Ltd.
    Beijing SL Pharm
    Shenzhen Main Luck Pharmaceuticals Inc.
    Shanxi Powerdone Pharmaceutics Co., Ltd.
    Luoxin Pharmaceutical Group Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral
    Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Breast Cancer
    Lymphoma
    Non-small Cell Lung Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Vinorelbine Market Report 2017
1 Vinorelbine Overview
    1.1 Product Overview and Scope of Vinorelbine
    1.2 Classification of Vinorelbine by Product Category
        1.2.1 United States Vinorelbine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Vinorelbine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Injection
    1.3 United States Vinorelbine Market by Application/End Users
        1.3.1 United States Vinorelbine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
        1.3.4 Non-small Cell Lung Cancer
        1.3.5 Others
    1.4 United States Vinorelbine Market by Region
        1.4.1 United States Vinorelbine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Vinorelbine Status and Prospect (2012-2022)
        1.4.3 Southwest Vinorelbine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Vinorelbine Status and Prospect (2012-2022)
        1.4.5 New England Vinorelbine Status and Prospect (2012-2022)
        1.4.6 The South Vinorelbine Status and Prospect (2012-2022)
        1.4.7 The Midwest Vinorelbine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Vinorelbine (2012-2022)
        1.5.1 United States Vinorelbine Sales and Growth Rate (2012-2022)
        1.5.2 United States Vinorelbine Revenue and Growth Rate (2012-2022)

2 United States Vinorelbine Market Competition by Players/Suppliers
    2.1 United States Vinorelbine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Vinorelbine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Vinorelbine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Vinorelbine Market Competitive Situation and Trends
        2.4.1 United States Vinorelbine Market Concentration Rate
        2.4.2 United States Vinorelbine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Vinorelbine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Vinorelbine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Vinorelbine Sales and Market Share by Region (2012-2017)
    3.2 United States Vinorelbine Revenue and Market Share by Region (2012-2017)
    3.3 United States Vinorelbine Price by Region (2012-2017)

4 United States Vinorelbine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Vinorelbine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Vinorelbine Revenue and Market Share by Type (2012-2017)
    4.3 United States Vinorelbine Price by Type (2012-2017)
    4.4 United States Vinorelbine Sales Growth Rate by Type (2012-2017)

5 United States Vinorelbine Sales (Volume) by Application (2012-2017)
    5.1 United States Vinorelbine Sales and Market Share by Application (2012-2017)
    5.2 United States Vinorelbine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Vinorelbine Players/Suppliers Profiles and Sales Data
    6.1 Pierre Fabre Pharmaceuticals, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Vinorelbine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 TEVA Pharms
        6.2.2 Vinorelbine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 TEVA Pharms Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Hospira, Inc.
        6.3.2 Vinorelbine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Hospira, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 West-Ward Pharmaceuticals Corp.
        6.4.2 Vinorelbine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Fresenius Kabi
        6.5.2 Vinorelbine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Fresenius Kabi Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 EBEWE Pharma (Sandoz A Novartis Division)
        6.6.2 Vinorelbine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
        6.7.2 Vinorelbine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Mylan
        6.8.2 Vinorelbine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Mylan Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Dr. Reddy's Laboratories
        6.9.2 Vinorelbine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Dr. Reddy's Laboratories Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
        6.10.2 Vinorelbine Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Nanjing Cuccess Pharmaceutical Co., Ltd
    6.12 Qilu Pharmaceutical (Hainan) Co., Ltd.
    6.13 Sinopharm A-Think Pharmaceutical Co., Ltd.
    6.14 Beijing SL Pharm
    6.15 Shenzhen Main Luck Pharmaceuticals Inc.
    6.16 Shanxi Powerdone Pharmaceutics Co., Ltd.
    6.17 Luoxin Pharmaceutical Group Co., Ltd.

7 Vinorelbine Manufacturing Cost Analysis
    7.1 Vinorelbine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Vinorelbine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Vinorelbine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Vinorelbine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Vinorelbine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Vinorelbine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Vinorelbine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Vinorelbine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Vinorelbine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer